Jolanta Niscigorska-Olsen
Overview
Explore the profile of Jolanta Niscigorska-Olsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aksak-Was B, Chober D, Serwin K, Scheibe K, Niscigorska-Olsen J, Niedzwiedz A, et al.
J Inflamm Res
. 2022 Sep;
15:4907-4920.
PMID: 36046662
Introduction: Remdesivir is the first agent with proven clinical efficacy against coronavirus disease 2019 (COVID-19); however, its benefit is associated with early use, and its efficacy has been poorly studied...
2.
Chober D, Aksak-Was B, Niscigorska-Olsen J, Niekrasz M, Parczewski M
Biomedicines
. 2022 Jul;
10(7).
PMID: 35884886
Introduction: Thromboembolic events, including mainly pulmonary embolisms and ischemic strokes, occur in up to one-third of COVID-19 patients. As efficacy of tocilizumab (TCZ) among patients with acute pulmonary embolism (PE)...
3.
Aksak-Was B, Ripa A, Szakola P, Horbacka K, Niscigorska-Olsen J, Witak-Jedra M, et al.
Infect Drug Resist
. 2021 Dec;
14:5027-5033.
PMID: 34880631
Introduction: infections are a growing problem worldwide. In recent years, infections with this bacteria have been reported in Central Europe, especially in the German Baltic coast but also in France...
4.
Wisniewska H, Skonieczna-Zydecka K, Parczewski M, Niscigorska-Olsen J, Karpinska E, Hornung M, et al.
J Clin Med
. 2021 Feb;
10(4).
PMID: 33572429
Liver injury-expressed as elevated liver enzymes-is common in patients with COVID-19. Little is known about the potential mechanisms of liver damage by SARS-CoV-2. A direct cytopathic effect on hepatocytes as...
5.
Tomasiewicz K, Piekarska A, Stempkowska-Rejek J, Serafinska S, Gawkowska A, Parczewski M, et al.
Expert Rev Anti Infect Ther
. 2020 Jul;
19(1):93-100.
PMID: 32693650
Background: Tocilizumab, an inhibitor of the interleukin-6 receptor, may decrease the inflammatory response and control the symptoms of severe coronavirus disease 2019 (COVID-19), but the evidence is scarce. Methods: This...
6.
Forminska K, Zasada A, Rastawicki W, Smietanska K, Bander D, Wawrzynowicz-Syczewska M, et al.
Ann Agric Environ Med
. 2015 Sep;
22(3):443-6.
PMID: 26403111
The study describes four cases of tularaemia - one developed after contact with rabbits and three developed after an arthropod bite. Due to non-specific clinical symptoms, accurate diagnosis of tularaemia...
7.
Nahorski W, Knap J, Pawlowski Z, Krawczyk M, Polanski J, Stefaniak J, et al.
PLoS Negl Trop Dis
. 2013 Jan;
7(1):e1986.
PMID: 23301116
Background: Alveolar echinococcosis (AE) caused by Echinococcus multilocularis infections is a dangerous old disease in the Northern Hemisphere. The aim of the paper was to collect and analyze data on...
8.
Niscigorska-Olsen J, Wodecka B, Moranska I, Skotarczak B
Ann Agric Environ Med
. 2008 Jun;
15(1):167-70.
PMID: 18581997
Borrelia burgdorferi sensu lato (s.l.) complex, the etiological factor of Lyme disease, includes over a dozen species of bacteria and 3 pathogenic within it. According to many authors, the clinical...